Expiration Date Extension for Dextran 40 (10% LMD in 0.9% Sodium Chloride Injection) Lot 07011JT through June 1, 2022
Audience: Pharmacy
September 29, 2021 -- This is to provide you with important information regarding Dextran 40 (10% LMD in 0.9% Sodium Chloride Injection), which is indicated to enhance blood flow, particularly in the microcirculation, and is manufactured by Hospira Inc., a Pfizer company.
Based upon FDA’s evaluation of stability data, FDA has extended the expiration date on one lot of 10% LMD in 0.9% Sodium Chloride Injection (#07011JT) in 500 mL bags for 11 months beyond its expiry date, as follows:
#07011JT: from July 1, 2021, to June 1, 2022.
The FDA is not requiring or recommending that the lots identified above be relabeled with new expiration dates. If you have bags of lot #07011JT in your current inventory, labeled with an expiration date of July 1, 2021, you may continue to maintain the product in your inventory and keep it available for use until June 1, 2022.
Please use available inventory on a first-in, first-out basis through the new expiration dates as noted above.
Source: FDA
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.